Literature DB >> 7197812

Use of chromogenic substrate S-2251 for determination of plasminogen activator in rat ovaries.

H Shimada, T Mori, A Takada, Y Takada, Y Noda, I Takai, H Kohda, T Nishimura.   

Abstract

A simple specific and reproducible method for determination of plasminogen activator activity in rat ovaries has been developed by using the chromogenic substrate S-2251. The two steps of enzymatic reactions, i.e. activation of plasminogen and subsequent hydrolysis of the substrate was performed in one step incubation. A linear relationship was observed between the amount of chromogen produced and activator activity in the range of the optical density form 0.05 to 1.20 for 30 min's incubation. Endogenous activity of non-specific proteases, plasmin or plasmin inhibitors which might be contained in rat ovaries turned out not to interfere with the specificity of a standardized assay procedure. Reproducibility was firmly established with coefficient of variation not exceeding 10%. Using this method, a marked increase followed by a drastic decrease in the activator activity was shown with rat ovaries around the time of ovulation after the injection of human chorionic gonadotropin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197812

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line.

Authors:  E Helseth; A Dalen; G Unsgaard; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

2.  Testosterone upregulation of tissue type plasminogen activator expression in Sertoli cells : tPA expression in Sertoli cells.

Authors:  Jian Guo; Yu-Qiang Shi; Wei Yang; Yin-Chuan Li; Zhao-Yuan Hu; Yi-Xun Liu
Journal:  Endocrine       Date:  2007-10-09       Impact factor: 3.633

3.  Variable response of tissue parameters of the fibrinolytic system to unilateral or bilateral adrenalectomy and unilateral or bilateral adrenal demedullation.

Authors:  A Smokovitis; N Kokolis; C Rekkas; T Ploumis
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

4.  Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours.

Authors:  K Inada; J Yamashita; S Matsuo; Y Nakashima; S Yamashita; M Ogawa
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

5.  Plasminogen activator activity in tears of pregnant women.

Authors:  Adrienne Csutak; Zita Steiber; József Tőzsér; Attila Jakab; András Berta; David M Silver
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

6.  SerpinE1 drives a cell-autonomous pathogenic signaling in Hutchinson-Gilford progeria syndrome.

Authors:  Chiara Nicoletti; Andrea Bracaglia; Giorgia Catarinella; Paola Procopio; Illari Salvatori; Marilena Taggi; Cristiana Valle; Alberto Ferri; Rita Canipari; Pier Lorenzo Puri; Lucia Latella
Journal:  Cell Death Dis       Date:  2022-08-26       Impact factor: 9.685

7.  Characterization of a 54 kDa, alpha 1-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient.

Authors:  N Tanaka; S Sekiya; H Takamizawa; N Kato; Y Moriyama; S Fujimura
Journal:  Jpn J Cancer Res       Date:  1991-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.